Solid Biosciences
Total Raised
$109.5MInvestors Count
17Deal Terms
2Funding, Valuation & Revenue
8 Fundings
Solid Biosciences has raised $109.5M over 8 rounds.
Solid Biosciences's latest funding round was a PIPE - II for $240M on March 6, 2026.
Solid Biosciences's valuation in January 2018 was $550M.
Solid Biosciences's 2024 revenue was $3.12M. Solid Biosciences's most recent revenue is from 2020.
Sign up for a free demo to see revenue data from 2020 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
3/6/2026 | PIPE - II | $240M | Bain Capital Life Sciences, Deep Track Capital, Invus Group, Janus Henderson Investors, Perceptive Advisors, RA Capital Management, Undisclosed Investors, and Vestal Point Capital | 4 | ||
1/8/2024 | PIPE | $3.12M FY 2024 | ||||
10/23/2020 | Corporate Minority - P2P | |||||
1/26/2018 | IPO | $550M | ||||
3/30/2017 | Series C |
Date | 3/6/2026 | 1/8/2024 | 10/23/2020 | 1/26/2018 | 3/30/2017 |
|---|---|---|---|---|---|
Round | PIPE - II | PIPE | Corporate Minority - P2P | IPO | Series C |
Amount | $240M | ||||
Investors | Bain Capital Life Sciences, Deep Track Capital, Invus Group, Janus Henderson Investors, Perceptive Advisors, RA Capital Management, Undisclosed Investors, and Vestal Point Capital | ||||
Valuation | $550M | ||||
Revenue | $3.12M FY 2024 | ||||
Sources | 4 |
Solid Biosciences Deal Terms
2 Deal Terms
Solid Biosciences's deal structure is available for 2 funding rounds, including their IPO from January 26, 2018.
Round | IPO | Series B |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IPO | |||||||||||||||
Series B |
Solid Biosciences Investors
17 Investors
Solid Biosciences has 17 investors. Perceptive Advisors invested in Solid Biosciences's PIPE - II funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
1/6/2014 | 3/6/2026 | 4 Series A, Series B (2015), PIPE (2024), PIPE - II (2026) | Hedge Fund | New York | ||
3/30/2017 | 3/6/2026 | 3 Series C, PIPE (2024), PIPE - II (2026) | Asset/Investment Management | Massachusetts | ||
1/8/2024 | 3/6/2026 | 2 PIPE, PIPE - II (2026) | Private Equity | California | ||
Asset/Investment Management | United Kingdom | |||||
Venture Capital | New York |
First funding | 1/6/2014 | 3/30/2017 | 1/8/2024 | ||
|---|---|---|---|---|---|
Last Funding | 3/6/2026 | 3/6/2026 | 3/6/2026 | ||
Investor | |||||
Rounds | 4 Series A, Series B (2015), PIPE (2024), PIPE - II (2026) | 3 Series C, PIPE (2024), PIPE - II (2026) | 2 PIPE, PIPE - II (2026) | ||
Board Seats | |||||
Type | Hedge Fund | Asset/Investment Management | Private Equity | Asset/Investment Management | Venture Capital |
Location | New York | Massachusetts | California | United Kingdom | New York |
Solid Biosciences Acquisitions
1 Acquisition
Solid Biosciences acquired 1 company. Their latest acquisition was AavantiBio on September 30, 2022.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
9/30/2022 | Series A | $108.08M | Acquired | 12 |
Date | 9/30/2022 |
|---|---|
Investment Stage | Series A |
Companies | |
Valuation | |
Total Funding | $108.08M |
Note | Acquired |
Sources | 12 |
Loading...